Regulation of the Immune Response by the Interaction of Chemokines and Proteases

Advances in Immunology

Volumn 81, Issue , 2003, Pages 1-44

  Struyf, Sofie ^a   Proost, Paul ^a   Van Damme, Jo ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; EOTAXIN; FRACTALKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PROTEINASE; RANTES;

ANGIOGENESIS; CYTOKINE PRODUCTION; HEMATOPOIESIS; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0142254121     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(03)81001-5     Document Type: Review

References (204)

1. + CXC chemokine-induced angiogenic activity. J. Immunol. 165, 5269-5277.
2. Annunziato, F., Cosmi, L., Galli, C., Beltrame, C., Romagnani, P., Manetti, R., Romagnani, S., and Maggi, E. (1999). Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J. Leukoc. Biol. 65, 691-699.
3. Annunziato, F., Galli, C., Cosmi, L., Romagnani, P., Manetti, R., Maggi, E., and Romagnani, S. (1998). Molecules associated with human Th1 or Th2 cells. Eur. Cytokine. Netw. 9(Suppl no. 3), 12-16.
4. Baird, J. W., Nibbs, R. J., Komai-Koma, M., Connolly, J. A., Ottersbach, K., Clark-Lewis, I., Liew, F. Y., and Craham, C. J. (1999). ESkine, a novel beta-chemokine, is differentially spliced to produce secretable and nuclear targeted isoforms. J. Biol. Chem. 274, 33496-33503.
5. Balter, M. (1996). New hope in HIV disease. Science 274, 1988-1989.
6. Bank, U., and Ansorge, S. (2001). More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J. Leukoc. Biol. 69, 197-206.
7. Begg, G. S., Pepper, D. S., Chesterman, C. N., and Morgan, F. J. (1978). Complete covalent structure of human beta-thromboglobulin. Biochemistry 17, 1739-1744.
8. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., and Strieter, R. M. (2000). CXC chemokines in angiogenesis. J. Leukoc. Biol. 68, 1-8.
9. Blaszczyk, J., Van Coillie, E., Proost, P., Van Damme, J., Opdenakker, C., Bujacz, C. D., Wang, J. M., and Ji, X. (2000). Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry 39, 14075-14081.
10. Blazquez, M. V., Madueño, J. A., Gonzalez, R., Jurado, R., Bachovchin, W. W., Peña, J., and Muñoz, E. (1992). Selective decrease of CD26 expression in T cells from HIV-infected individuals. J. Immunol. 149, 3073-3077.
11. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., and Springer, T. A. (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833.
12. Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., and Mackay, C. R. (1997). The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925-1930.
13. Böhm, S. K., Grady, E. F., and Bunnett, N. W. (1997). Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J. 322, 1-18.
14. Brandt, E., Van Damme, J., and Flad, H.-D. (1991). Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Cytokine 3, 311-321.
15. Brandt, E., Petersen, F., Ludwig, A., Ehlert, J. E., Bock, L., and Flad, H. D. (2000). The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J. Leukoc. Biol. 67, 471-478.
16. Broder, C. C., Nussbaum, O., Gutheil, W. G., Bachovchin, W. W., Berger, E. A., Patience, C., McKnight, A., Clapham, P. R., Boyd, M. T., Weiss, R. A., Schulz, T. F., Camerini, D., Planelles, V., Chen, I. S., Alizon, M., Dragic, T., Callebaut, C., Jacotot, E., Krust, B., and Hovanessian, A. G. (1994). CD26 antigen and HIV fusion? Science 264, 1156-1165.
17. Broxmeyer, H. E., Cooper, S., Cacalano, G., Hague, N. L., Bailish, E., and Moore, M. W. (1996). Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue. J. Exp. Med. 184, 1825-1832.
18. Broxmeyer, H. E., Cooper, S., Hangoc, G., Gao, J.-L., and Murphy, P. M. (1999a). Dominant myelopoietic effector functions mediated by chemokine receptor CCR1. J. Exp. Med. 189, 1987-1992.
19. Broxmeyer, H. E., and Kim, C. H. (1999b). Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp. Hematol. 27, 1113-1123.
20. Bühling, F., Kunz, D., Reinhold, D., Ulmer, A. J., Ernst, M., Flad, H.-D., and Ansorge, S. (1994). Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat. Immun. 13, 270-279.
21. + T cells expressing relatively high levels of CD26. Exp. Cell Res. 241, 352-362.
22. Campbell, J. J., Foxman, E. F., and Butcher, E. C. (1997). Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration. Eur. J. Immunol. 27, 2571-2578.
23. Campbell, J. J., Pan, J., and Butcher, E. C. (1999). Cutting edge: developmental switches in chemokine responses during T cell maturation. J. Immunol. 163, 2353-2357.
24. Car, B. D., Baggiolini, M., and Walz, A. (1991). Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases. Biochem. J. 275, 4.
25. + T cells. Science 276, 273-276.
26. Chan, D. C., and Kim, P. S. (1998). HIV entry and its inhibition. Cell 93, 681-684.
27. Charbonnier, A.-S., Kohrgruber, N., Kriehuber, E., Stingl, G., Rot, A., and Maurer, D. (1999). Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J. Exp. Med. 190, 1755-1768.
28. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C., and Sodroski, J. (1996). The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
29. Chou, C.-C., Fine, J. S., Puglies-Sivo, C., Gonsiorek, W., Davies, L., Deno, G., Petro, M., Schwarz, M., Zavodny, P. J., and Hipkin, R. W. (2002). Pharmacological characterization of the chemokine receptor hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1β. Br. J. Pharmacol. 137, 663-675.
30. + progenitor cells. J. Immunol. 169, 7000-7008.
31. Clark-Lewis, I., Dewald, B., Loetscher, M., Moser, B., and Baggiolini, M. (1994). Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J. Biol. Chem. 269, 16075-16081.
32. Coechi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., and Lusso, P. (1995). Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815.
33. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Cara, A., Gallo, R. C., and Lusso, P. (1996). The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2, 1244-1247.
34. Cohen, A. B., Stevens, M. D., Miller, E. J., Atkinson, M. A., and Mullenbach, G. (1992). Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets. Am. J. Physiol. 263, 249-256.
35. Crump, M. P., Gong, J.-H., Loetscher, P., Rajarathnam, K., Amara, A., Arenzana-Seisdedos, F., Virelizier, J.-L., Baggiolini, M., Sykes, B. D., and Clark-Lewis, I. (1997). Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16, 6996-7007.
36. Culley, F. J., Brown, A., Conroy, D. M., Sabroe, I., Pritchard, D. I., and Williams, T. J. (2000). Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo. J. Immunol. 165, 6447-6453.
37. D'Amico, G., Frascaroli, G., Bianchi, G., Transidico, P., Doni, A., Vecchi, A., Sozzani, S., Allavena, P., and Mantovani, A. (2000). Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 1, 387-391.
38. Darmoul, D., Lacasa, M., Baricault, L., Marguet, D., Sapin, C., Trotot, P., Barbat, A., and Trugnan, G. (1992). Dipeptidyl peptidase IV (CD26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J. Biol. Chem. 267, 4824-4833.
39. David, N. B., Sapède, D., Saint-Etienne, L., Thisse, C., Thisse, B., Dambly-Chaudière, C., Rosa, F. M., and Ghysen, A. (2002). Molecular basis of cell migration in the fish lateral line: role of the chemokine receptor CXCR4 and of its ligand, SDF-1. Proc. Natl. Acad. Sci. USA 99, 16297-16302.
40. De Meester, I., Korom, S., Van Damme, J., and Scharpé, S. (1999). CD26, let it cut or cut it down. Immunol. Today 20, 367-375.
41. Delgado, M. B., Clark-Lewis, I., Loetscher, P., Langen, H., Thelen, M., Baggiolini, M., and Wolf, M. (2001). Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur. J. Immunol. 31, 699-707.
42. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R., and Landau, N. R. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
43. Deng, X., Ueda, H., Su, S. B., Gong, W., Dunlop, N. M., Gao, J. L., Murphy, P. M., and Wang, J. M. (1999). A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. Blood 94, 1165-1173.
44. Detheux, M., Ständker, L., Vakili, J., Münch, J., Forssmann, U., Adermann, K., Pöhlmann, S., Vassart, G., Kirchhoff, F., Parmentier, M., and Forssmann, W.-G. (2000). Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. J. Exp. Med. 192, 1501-1508.
45. DeVico, A. L., Pal, R., and Markham, P. D. (1998). β-chemokine MDC and HIV-1 infection. Science 281, 487.
46. Dieu-Nosjean, M.-C., Vicari, A., Lebecque, S., and Caux, C. (1999). Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J. Leukoc. Biol. 66, 252-262.
47. Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., and Caux, C. (1998). Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386.
48. Doms, R. W., and Trono, D. (2000). The plasma membrane as a combat zone in the HIV battlefield. Genes Dev. 14, 2677-2688.
49. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., and Doms, R. W. (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158.
50. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 661-673.
51. Fox, D. A., Hussey, R. E., Fitzgerald, K. A., Acuto, O., Poole, C., Palley, L., Daley, J. F., Schlossman, S. F., and Reinherz, E. L. (1984). Tal, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J. Immunol. 133, 1250-1256.
52. Förster, R., Mattis, A. E., Kremmer, E., Wolf, E., Brem, G., and Lipp, M. (1996). A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037-1047.
53. Fra, A.M., Locati, M., Otero, K., Sironi, M., Signorelli, P., Massardi, M.L., Gobbi, M., Vecchi, A., Sozzani, S., and Mantovani, A. (2003). Scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J. Immunol. 170, 2279-2282.
54. Galli, G., Chantry, D., Annunziato, F., Romagnani, P., Cosmi, L., Lazzeri, E., Manetti, R., Maggi, E., Gray, P. W., and Romagnani, S. (2000). Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur. J. Immunol. 30, 204-210.
55. Gerard, C., and Rollins, B. J. (2001). Chemokines and disease. Nat. Immunol. 2, 108-115.
56. Gerli, R., Muscat, C., Bertotto, A., Bistoni, O., Agea, E., Tognellini, R., Fiorucci, G., Cesarotti, M., and Bombardieri, S. (1996). CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis. Clin. Immunol. Immunopathol. 80, 31-37.
57. Gimbrone, M. A., Obin, M. S., Brock, A. F., Luis, E. A., Hass, P. E., Hébert, C. A., Yip, Y. K., Leung, D. W., Lowe, D. G., Kohr, W. J., Darbonne, W. C., Bechtol, K. B., and Baker, J. B. (1989). Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 246, 1601-1603.
58. Graham, G. J., Wright, E. G., Hewick, R., Wolpe, S. D., Wilkie, N. M., Donaldson, D., Lorimore, S., and Pragnell, I. B. (1990). Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344, 442-444.
59. Gregory, H., Young, J., Schröder, J.-M., Mrowietz, U., and Christophers, E. (1988). Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem. Biophys. Res. Commun. 151, 883-890.
60. Guan, E., Wang, J., Roderiquez, G., and Norcross, M. A. (2002). Natural truncation of the chemokine MIP-1β/CCL4 affects receptor specificity but not anti-HIV-1 activity. J. Biol. Chem. 277, 32348-32352.
61. Gunn, M. D., Ngo, V. N., Ansel, K. M., Ekland, E. H., Cyster, J. G., and Williams, L. T. (1998). A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391, 799-803.
62. Gupta, S. K., Hassel, T., and Singh, J. P. (1995). A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc. Natl. Acad. Sci. USA 92, 7799-7803.
63. Hasegawa, H., Nomura, T., Kohno, M., Tateishi, N., Suzuki, Y., Maeda, N., Fujisawa, R., Yoshie, O., and Fujita, S. (2000). Increased chemokine receptor CCB7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood 95, 30-38.
64. Herrera, C., Morimoto, C., Blanco, J., Mallol, J., Arenzana, F., Lluis, C., and Franco, R. (2001). Comodulation of CXCR4 and CD26 in human lymphocytes. J. Biol. Chem. 276, 19532-19539.
65. Hébert, C. A., Luscinskas, F. W., Kiely, J.-M., Luis, E. A., Darbonne,W. C., Bennett, G. L., Liu, C. C., Obin, M. S., Gimbrone, M. A., and Baker, J. B. (1990). Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J. Immunol. 145, 3033-3040.
66. Hoffman, T. L., LaBranche, C. C., Zhang, W., Canziani, G., Robinson, J., Chaiken, I., Hoxie, J. A., and Doms, R. W. (1999). Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Proc. Natl. Acad. Sci. USA 96, 6359-6364.
67. Holt, J. C., Harris, M. E., Holt, A. M., Lange, E., Henschen, A., and Niewiarowski, S. (1986). Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin. Biochemistry 25, 1988-1996.
68. Hopsu-Havu, V. K., and Glenner, G. G. (1966). A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide. Histochemie 7, 197-201.
69. Horuk, R. (1994). The Interleukin-8-receptor family: from chemokines to malaria. Immunol. Today 15, 169-174.
70. Hunter, M. G., Bawden, L., Brotherton, D., Craig, S., Cribbes, S., Czaplewski, L. G., Dexter, T. M., Drummond, A. H., Gearing, A. H., Heyworth, C. M., Lord, B. I., McCourt, M., Varley, P. G., Wood, L. M., Edwards, R. M., and Lewis, P. J. (1995). BB-10010: an active variant of human macrophage inflammatory protein-1α with improved pharmaceutical properties. Blood 86, 4400-4408.
71. Iida, N., Haisa, M., Igarashi, A., Pencev, D., and Grotendorst, G. R. (1996). Leukocyte-derived growth factor links the PDGF and CXC chemokine families of peptides. FASEB J. 10, 1336-1345.
72. Iwata, S., and Morimoto, C. (1999a). CD26/dipeptidyl peptidase IV in context: the different roles of a multifunctional ectoenzyme in malignant transformation. J. Exp. Med. 190, 301-305.
73. Iwata, S., Yamaguchi, N., Munakata, Y., Ikushima, H., Lee, J. F., Hosono, O., Schlossman, S. F., and Morimoto, C. (1999b). CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. Int. Immunol. 11, 417-426.
74. Kanayama, N., Kajiwara, Y., Goto, J., El Maradny, E., Maehara, K., Andou, K., and Terao, T. (1995). Inactivation of interleukin-8 by aminopeptidase N (CD13). J. Leukoc. Biol. 57, 129-134.
75. King, A. G., Johanson, K., Frey, C. L., DeMarsh, P. L., White, J. R., McDevitt, P., McNulty, D., Balcarek, J., Jonak, Z. L., Bhatnagar, P. K., and Pelus, L. M. (2000). Identification of unique truncated KC/GRO beta chemokines with potent hematopoietic and anti-infective activities. J. Immunol. 164, 3774-3782.
76. King, A. G., Horowitz, D., Dillon, S. B., Levin, R., Farese, A. M., MacVittie, T. J., and Pelus, L. M. (2001). Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GROß. Blood 97, 1534-1542.
77. Kinter, A., Arthos, J., Cicala, C., and Fauci, A. S. (2000). Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunol. Rev. 177, 88-98.
78. Knaut, H., Werz, C., Geisler, R., The Tübingen 2000 screen consortium, and Nüsslein-Volhard, C. (2003). A zebrafish homologue of the chemokine receptor CXCR4 is a germ-cell guidance receptor. Nature 421, 279-282.
79. Kuhmann, S. E., Platt, E. J., Kozak, S. L., and Kabat, D. (2000). Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J. Virol. 74, 7005-7015.
80. Kunkel, S. L., Lukacs, N., Kasama, T., and Strieter, R. M. (1996). The role of chemokines in inflammatory joint disease. J. Leukoc. Biol. 59, 6-12.
81. Lai, J.-P., Ho, W.-Z., Zhan, G.-X., Yi, Y., Collman, R. G., and Douglas, S. D. (2001). Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc. Natl. Acad. Sci. USA 98, 3970-3975.
82. Lambeir, A.-M., Proost, P., Durinx, C., Bal, G., Senten, K., Augustyns, K., Scharpé, S., Van Damme, J., and De Meester, I. (2001). Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J. Biol. Chem. 276, 29839-29845.
83. Laterveer, L., Lindley, I. J., Hamilton, M. S., Willemze, R., and Fibbe, W. E. (1995). Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 85, 2269-2275.
84. Lee, B., and Montaner, L. J. (1999). Chemokine immunobiology in HIV-1 pathogenesis. J. Leukoc. Biol. 65, 552-565.
85. Lindley, I., Aschauer, H., Seifert, J.-M., Lam, C., Brunowsky, W., Kownatzki, E., Thelen, M., Peveri, P., Dewald, B., von Tscharner, V., Walz, A., and Baggiolini, M. (1988). Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc. Natl. Acad. Sci. USA 85, 9199-9203.
86. Littman, D. R. (1998). Chemokine receptors: keys to AIDS pathogenesis?. Cell 93, 677-680.
87. Locati, M., Otero, K., Schioppa, T., Signorelli, P., Perrier, P., Baviera, S., Sozzani, S., and Mantovani, A. (2002). The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses. Allergy 57, 972-982.
88. Loetscher, M., Loetscher, P., Brass, N., Meese, E., and Moser, B. (1998). Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol. 28, 3696-3705.
89. Luster, A. D., Greenberg, S. M., and Leder, P. (1995). The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182, 219-231.
90. Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., and Springer, T. A. (1998). Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95, 9448-9453.
91. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., and Sharpe, R. J. (1990). Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-79.
92. Malkowski, M. G., Lazar, J. B., Johnson, P. H., and Edwards, B. F. (1997). The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence. J. Mol. Biol. 266, 367-380.
93. Marguet, D., Baggio, L., Kobayashi, T., Bernard, A.-M., Pierres, M., Nielsen, P. F., Ribel, U., Watanabe, T., Drucker, D. J., and Wagtmann, N. (2000). Enhanced insulin secretion and improved glucose toleranee in mice lacking CD26. Proc. Natl. Acad. Sci. USA 97, 6874-6879.
94. Martinelli, R., Sabroe, I., LaRosa, G., Williams, T. J., and Pease, J. E. (2001). The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b. J. Biol. Chem. 276, 42957-42964.
95. McQuibban, G. A., Gong, J.-H., Tam, E. M., McCulloch, C. A., Clark-Lewis, I., and Overall, C. M. (2000). Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206.
96. McQuibban, G. A., Butler, G. S., Gong, J.-H., Bendall, L., Power, C., Clark-Lewis, I., and Overall, C. M. (2001). Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508.
97. McQuibban, G. A., Gong, J.-H., Wong, J. P., Wallace, J. L., Clark-Lewis, I., and Overall, C. M. (2002). Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100, 1160-1167.
98. Melchers, F., Rolink, A. G., and Schaniel, C. (1999). The role of chemoldnes in regulating cell migration during humoral immune responses. Cell 99, 351-354.
99. Mellado, M., Rodriguez-Frade, J. M., Vila-Coro, A. J., de Ana, A. M., and Martinez-A., C. (1999). Chemokine control of HIV-1 infection. Nature 400, 723-724.
100. Menten, P., Struyf, S., Schutyser, E., Wuyts, A., De Clercq, E., Schols, D., Proost, P., and Van Damme, J. (1999). The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. J. Clin. Invest. 104, R1-R5.
101. Mentlein, R. (1999). Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul. Pept. 85, 9-24.
102. Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., Lam, C., Auer, M., Hub, E., and Rot, A. (1997). Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91, 385-395.
103. Mochizuki, M., Bartels, J., Mallet, A. I., Christophers, E., and Schröder, J.-M. (1998). IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J. Immunol. 160, 60-68.
104. Monteclaro, F. S., and Charo, I. F. (1997). The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1. Receptor activation by a pseudo-tethered ligand. J. Biol. Chem. 272, 23186-23190.
105. Morimoto, C., and Schlossman, S. F. (1998). The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161, 55-70.
106. Murdoch, C., and Finn, A. (2000). Chemokine receptors and their role in inflammation and infections diseases. Blood 95, 3032-3043.
107. Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., and Power, C. A. (2000). International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176.
108. Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verástegui, E., and Zlotnik, A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
109. Nagasawa, T., Kikutani, H., and Kishimoto, T. (1994). Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc. Natl. Acad. Sci. USA 91, 2305-2309.
110. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H., and Kishimoto, T. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635-638.
111. Nakagawa, H., Hatakeyama, S., Ikesue, A., and Miyai, H. (1991). Generation of interleukin-8 by plasmin from AVLPR-interleuldn-8, the human fibroblast-derived neutrophil chemotactic factor. FEBS Lett. 282, 412-414.
112. Nibbs, R. J. B., Wylie, S. M., Yang, J., Landau, N. R., and Graham, G. J. (1997). Cloning and characterisation of a novel promiscuous human β-chemokine receptor D6. J. Biol. Chem. 272, 32078-32083.
113. Nibbs, R. J. B., Kriehuber, E., Ponath, P. D., Parent, D., Qin, S., Campbell, J. D. M., Henderson, A., Kerjaschki, D., Maurer, D., Graham, G. J., and Rot, A. (2001). The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 158, 867-877.
114. Noso, N., Sticherling, M., Bartels, J., Mallet, A. I., Christophers, E., and Schröder, J.-M. (1996). Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts. J. Immunol. 156, 1946-1953.
115. Noso, N., Bartels, J., Mallet, A. I., Mochizuki, M., Christophers, E., and Schröder, J.-M. (1998). Delayed production of biologically active O-glycosylated forms of human eotaxin by TNFα-stimulated dermal fibroblasts. Eur. J. Biochem. 253, 114-122.
116. Nourshargh, S., Perkins, J. A., Showell, H. J., Matsushima, K., Williams, T. J., and Collins, P. D. (1992). A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8. J. Immunol. 148, 106-111.
117. Nufer, O., Corbett, M., and Walz, A. (1999). Amino-terminal processing of chemokine ENA-78 regulates biological activity. Biochemistry 38, 636-642.
118. O'Brien, S. J., and Moore, J. P. (2000). The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol. Rev. 177, 99-111.
119. Ogilvie, P., Bardi, G., Clark-Lewis, I., Baggiolini, M., and Uguccioni, M. (2001). Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97, 1920-1924.
120. Ohtsuki, T., Hosono, O., Kobayashi, H., Munakata, Y., Souta, A., Shioda, T., and Morimoto, C. (1998). Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV. FEBS Lett. 431, 236-240.
121. Opdenakker, G., Van den Steen, P. E., and Van Damme, J. (2001). Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22, 571-579.
122. Oppenheim, J. J., Zachariae, C. O., Mukaida, N., and Matsushima, K. (1991). Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9, 617-648.
123. Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E., and Norcross, M. A. (1997). Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186, 1865-1872.
124. Padrines, M., Wolf, M., Walz, A., and Baggiolini, M. (1994). Inteleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352, 231-235.
125. Pal, R., Garzino-Demo, A., Markham, P. D., Burns, J., Brown, M., Gallo, R. C., and DeVico, A. L. (1997). Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 278, 695-698.
126. Proost, P., Wuyts, A., Conings, R., Lenaerts, J.-P., Billiau, A., Opdenakker, G., and Van Damme, J. (1993a). Human and bovine granulocyte chemotactic protein-2: complete amino acid sequence and functional characterization as chemokines. Biochemistry 32, 10170-10177.
127. Proost, P., De Wolf-Peeters, C., Conings, R., Opdenakker, G., Billiau, A., and Van Damme, J. (1993b). Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10 and IL-8. J. Immunol. 150, 1000-1010.
128. Proost, P., Struyf, S., Couvreur, M., Lenaerts, J.-P., Conings, R., Menten, P., Verhaert, P., Wuyts, A., and Van Damme, J. (1998a). Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. J. Immunol. 160, 4034-4041.
129. Proost,P., Struyf, S., Schols, D., Durinx, C., Wuyts, A., Lenaerts, J.-P., De Clercq, E., De Meester, I., and Van Damme, J. (1998b). Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha. FEBS Lett. 432, 73-76.
130. Proost, P., De Meester, I., Schols, D., Struyf, S., Lambeir, A.-M., Wuyts, A., Opdenakker, G., De Clercq, E., Scharpé, S., and Van Damme, J. (1998c). Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 273, 7222-7227.
131. Proost, P., Struyf, S., Schols, D., Opdenakker, G., Sozzani, S., Allavena, P., Mantovani, A., Augustyns, K., Bal, G., Haemers, A., Lambeir, A.-M., Scharpé, S., Van Damme, J., and De Meester, I. (1999). Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J. Biol. Chem. 274, 3988-3993.
132. Proost, P., Menten, P., Struyf, S., Schutyser, E., De Meester, I., and Van Damme, J. (2000). Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonist. Blood 96, 1674-1680.
133. Proost, P., Schutyser, E., Menten, P., Struyf, S., Wuyts, A., Opdenakker, G., Detheux, M., Parmentier, M., Durinx, C., Lambeir, A.-M., Neyts, J., Liekens, S., Maudgal, P., Billiau, A., and Van Damme, J. (2001). Aminoterminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving anti-angiogenic properties. Blood 98, 3554-3561.
134. Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., and Mackay, C. R. (1998). The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101, 746-754.
135. Reeves, J. D., Hibbitts, S., Simmons, G., McKnight, A., Azevedo-Pereira, J. M., Moniz-Pereira, J., and Clapham, P. R. (1999). Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. J. Virol. 73, 7795-7804.
136. Richter, R., Schulz-Knappe, P., John, H., and Forssmann, W.-G. (2000). Posttranslationally processed forms of the human chemokine HCC-1. Biochemistry 39, 10799-10805.
137. Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., and Sodroski, J. (1998). A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280, 1949-1953.
138. Rollins, B. J. (1997). Chemokines. Blood 90, 909-928.
139. Rossi, D., and Zlotnik, A. (2000). The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242.
140. Sabroe, I., Hartnell, A., Jopling, L. A., Bel, S., Ponath, P. D., Pease, J. E., Collins, P. D., and Williams, T. J. (1999). Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J. Immunol. 162, 2946-2955.
141. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., and Lanzavecchia, A. (1998). Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769.
142. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G., and Parmentier, M. (1996). Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
143. Sato, Y., Abe, M., and Takaki, R. (1990). Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem. Biophys. Res. Commun. 172, 595-600.
144. Scarlatti, G., Tresoldi, E., Björndal, A., Fredriksson, R., Colognesi, C., Deng, H. K., Malnati, M. S., Plebani, A., Siccardi, A. G., Littman, D. R., Fenyö, E. M., and Lusso, P. (1997). In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3, 1259-1265.
145. Schaniel, C., Sallusto, F., Ruedl, C., Sideras, P., Melchers, F., and Rolink, A. G. (1999). Three chemokines with potential functions in T lymphocyte-independent and -dependent B lymphocyte stimulation. Eur. J. Immunol. 29, 2934-2947.
146. Schaniel, C., Rolink, A., G., and Melchers, F. (2001). Attractions and migrations of lymphoid cells in the organization of humoral immune responses. Adv. Immunol. 78, 111-168.
147. Scheel-Toellner, D., Richter, E., Toellner, K.-M., Reiling, N., Wacker, H.-H., Flad, H.-D., and Gerdes, J. (1995). CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma. Lab. Invest. 73, 685-690.
148. Schmid, J., and Weissmann, C. (1987). Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes. J. Immunol. 139, 250-256.
149. Schols, D., Proost, P., Struyf, S., Wuyts, A., De Meester, I., Scharpé, S., Van Damme, J., and De Clercq, E. (1998). CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity. Antiviral Res. 39, 175-187.
150. Schröder, J. M., Mrowietz, U., Morita, E., and Christophers, E. (1987). Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J. Immunol. 139, 3474-3483.
151. Schröder, J.-M., Mrowietz, U., and Christophers, E. (1988). Identification of different charged species of a human monocyte derived neutrophil activating peptide (MONAP). Biochem. Biophys. Res. Commun. 152, 277-284.
152. Schröder, J. M., Sticherling, M., Henneicke, H. H., Preissner, W. C., and Christophers, E. (1990). IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J. Immunol. 144, 2223-2232.
153. Schulz-Knappe, P., Mägert, H.-J., Dewald, B., Meyer, M., Cetin, Y., Kubbies, M., Tomeczkowski, J., Kirchhoff, K., Raida, M., Adermann, K., Kist, A., Reinecke, M., Sillard, R., Pardigol, A., Uguccioni, M., Baggiolini, M., and Forssmann, W.-G. (1996). HCC-1, a novel chemokine from human plasma. J. Exp. Med. 183, 295-299.
154. Schutyser, E., Struyf, S., Wuyts, A., Put, W., Geboes, K., Grillet, B., Opdenakker, G., and Van Damme, J. (2001). Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. Eur. J. Immunol. 31, 3755-3762.
155. Shioda, T., Kato, H., Ohnishi, Y., Tashiro, K., Ikegawa, M., Nakayama, E. E., Hu, H., Kato, A., Sakai, Y., Liu, H., Honjo, T., Nomoto, A., Iwamoto, A., Morimoto, C., and Nagai, Y. (1998). Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. USA 95, 6331-6336.
156. Sica, A., Saccani, A., Borsatti, A., Power, C. A., Wells, T. N., Luini, W., Polentarutti, N., Sozzani, S., and Mantovani, A. (1997). Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185, 969-974.
157. Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K., Hilgartner, M. W., and O'Brien, S. J. (1997). Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277, 959-965.
158. Sozzani, S., Allavena, P., D'Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R., and Mantovani, A. (1998). Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161, 1083-1086.
159. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., Shan, S.-Y., Roczniak, S., and Shanafelt, A. B. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357.
160. Struyf, S., De Meester, I., Scharpé, S., Lenaerts, J.-P., Menten, P., Wang, J. M., Proost, P., and Van Damme, J. (1998a). Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur. J. Immunol. 28, 1262-1271.
161. 2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J. Immunol. 161, 2672-2675.
162. Struyf, S., Van Collie, E., Paemen, L., Put, W., Lenaerts, J.-P., Proost, P., Opdenakker, G., and Van Damme, J. (1998c). Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells. J. Leukoc. Biol. 63, 364-372.
163. Struyf, S., Proost, P., Schols, D., De Clercq, E., Gpdenakker, G., Lenaerts, J.-P., Detheux, M., Parmentier, M., De Meester, I., Scharpé, S., and Van Damme, J. (1999). CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J. Immunol. 162, 4903-4909.
164. Struyf, S., Menten, P., Lenaerts, J.-P., Put, W., D'Haese, A., De Clercq, E., Schols, D., Proost, P., and Van Damme, J. (2001a). Diverging binding capacities of natural LD78fi isoforms of macrophage inflammatory protein-1α to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur. J. Immunol. 31, 2170-2178.
165. Struyf, S., Proost, P., Lenaerts, J.-P., Stoops, G., Wuyts, A., and Van Damme, J. (2001b). Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1. Blood 97, 2197-2204.
166. Struyf, S., Stoops, G., Van Coillie, E., Gouwy, M., Schutyser, E., Lenaerts, J.-P., Fiten, P., Van Aelst, I., Proost, P., Opdenakker, G., and Van Damme, J. (2001c). Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants. Biochemistry 40, 11715-11722.
167. Tanaka, Y., Imai, T., Baba, M., Ishikawa, I., Uehira, M., Nomiyama, H., and Yoshie, O. (1999). Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur. J. Immunol. 29, 633-642.
168. Tang, H. L., and Cyster, J. G. (1999). Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. Science 284, 819-822.
169. Tilton, B., Ho, L., Oberlin, E., Loetscher, P., Baleux, F., Clark-Lewis, I., and Thelen, M. (2000). Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J. Exp. Med. 192, 313-324.
170. Tomhave, E. D., Richardson, R. M., Didsbury, J. R, Menard, L., Snyderman, R., and Ali, H. (1994). Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J. Immunol. 153, 3267-3275.
171. Torimoto, Y., Dang, N. H., Vivier, E., Tanaka, T., Schlossman, S. F., and Morimoto, C. (1991). Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J. Immunol. 147, 2514-2517.
172. Vakili, J., Ständker, L., Detheux, M., Vassart, G., Forssmann, W.-G., and Parmentier, M. (2001). Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active [9-74] processed variant. J. Immunol. 167, 3406-3413.
173. Valenzuela-Fernandez, A., Planchenault, T., Baleux, F., Staropoli, I., Le-Barillec, K., Leduc, D., Delaunay, T., Lazarini F., Virelizier, J.-L., Chignard, M., Pidard, D., and Arenzana-Seisdedos, F. (2002). Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J. Biol. Chem. 277, 15677-15689.
174. Van Coillie, E., Proost, P., Van Aelst, I., Struyf, S., Polfliet, M., De Meester, I., Harvey, D. J., Van Damme, J., and Opdenakker, G. (1998). Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37, 12672-12680.
175. 2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J. Exp. Med. 167, 1364-1376.
176. Van Damme, J., Decock, B., Conings, R., Lenaerts, J.-P., Opdenakker, G., and Billiau, A. (1989a). The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8. Eur. J. Immunol. 19, 1189-1194.
177. Van Damme, J., Van Beeumen, J., Conings, R., Decock, B., and Billiau, A. (1989b). Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin. Eur. J. Biochem. 181, 337-344.
178. Van Damme, J., Proost, P., Lenaerts, J.-P., and Opdenakker, G. (1992). Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176, 59-65.
179. Van Damme, J., Proost, P., Put, W., Arens, S., Lenaerts, J.-P., Conings, R., Opdenakker, G., Heremans, H., and Billiau, A. (1994). Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J. Immunol. 152, 5495-5502.
180. Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., and Opdenakker, G. (2000). Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96, 2673-2681.
181. Vanham, G., Kestens, L., De Meester, I., Vingerhoets, J., Penne, G., Vanhoof, G., Scharpé, S., Heyligen, H., Bosmans, E., Ceuppens, J. L., and Gigase, P. (1993). Decreased expression of the memory marker CD26 on both CD4 + and CD8 + T lymphocytes of HIV-infected subjects. J. Acquir. Imm. Defic. Syndr. 6, 749-757.
182. Verfaillie, C. M., Catanzarro, P. M., and Li, W.-N. (1994). Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J. Exp. Med. 179, 643-649.
183. Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H., and Matsushima, K. (1999). Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104, 1097-1105.
184. von Bonin, A., Hühn, J., and Fleischer, B. (1998). Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol. Rev. 161, 43-53.
185. Vulcano, M., Albanesi, C., Stoppacciaro, A., Bagnati, R., D'Amico, G., Struyf, S., Transidico, P., Bonecchi, R., Del Prete, A., Allavena, P., Ruco, L. P., Chiabrando, C., Girolomoni, G., Mantovani, A., and Sozzani, S. (2001). Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 31, 812-822.
186. Walz, A., Peveri, P., Aschauer, H., and Baggiolini, M. (1987). Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 149, 755-761.
187. Walz, D. A., Wu, V. Y., de Lamo, R., Dene, H., and McCoy, L. E. (1977). Primary structure of human platelet factor 4. Thromb. Res. 11, 893-898.
188. Wang, J. M., Chertov, O., Proost, P., Li, J. J., Menten, P., Xu, L., Sozzani, S., Mantovani, A., Gong, W., Schirrmacher, V., Van Damme, J., and Oppenheim, J. J. (1998). Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NFkappaB activation. Int. J. Cancer 75, 900-907.
189. Wesley, U. V., Albino, A. P., Tiwari, S., and Houghton, A. N. (1999). A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J. Exp. Med. 190, 311-322.
190. Willheim, M., Ebner, C., Baier, K., Kern, W., Schrattbauer, K., Thien, R., Kraft, D., Breiteneder, H., Reinisch, W., and Scheiner, O. (1997). Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J. Allergy Clin. Immunol. 100, 348-355.
191. Wuyts, A., Govaerts, C., Struyf, S., Lenaerts, J.-P., Put, W., Conings, R., Proost, P., and Van Damme, J. (1999a). Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms. Eur. J. Biochem. 260, 421-429.
192. Wuyts, A., Struyf, S., Proost, P., and Van Damme, J. (1999b). Chemokines, in Thèze, J. (ed.) "The cytokine network and immune functions" Oxford, Oxford University Press, pp. 125-145.
193. Xiao, L., Owen, S. M., Goldman, I., Lal, A. A., deJong, J. J., Goudsmit, J., and Lal, R. B. (1998). CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 240, 83-92.
194. Xin, X., Shioda, T., Kato, A., Liu, H., Sakai, Y., and Nagai, Y. (1999). Enhanced anti-HIV-1 activity of CC-chemoldne LD78β, a non-allelic variant of MIP-1α/LD78α. FEBS Lett. 457, 219-222.
195. Yanagihara, S., Komura, E., Nagafune, J., Watarai, H., and Yamaguchi, Y. (1998). EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 161, 3096-3102.
196. Yaron, A., and Naider, F. (1993). Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28, 31-81.
197. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.
198. Yoshie, O., Imai, T., and Nomiyama, H. (2001). Chemokines in immunity. Adv. Immunol. 78, 57-110.
199. Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., and Leonard, E. J. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84, 9233-9237.
200. Yoshimura, T., Robinson, E. A., Appella, E., Matsushima, K., Showalter, S. D., Skeel, A., and Leonard, E. J. (1989). Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol. Immunol. 26, 87-93.
201. Youn, B.-S., Zhang, S. M., Broxmeyer, H. E., Cooper, S., Antol, K., Fraser, M., and Kwon, B. S. (1998). Characterization of CKbeta8 and CKbeta8-1: two alternatively spliced forms of human beta-chemokine, chemoattractants for neutrophils, monocytes, and lymphocytes, and potent agonists at CC chemokine receptor 1. Blood 91, 3118-3126.
202. Youn, B.-S., Mantel, C., and Broxmeyer, H. E. (2000). Chemokines, chemokine receptors and hematopoiesis. Immunol. Rev. 177, 150-174.
203. Zlotnik, A., Morales, J., and Hedrick, J. A. (1999). Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol. 19, 1-47.
204. Zlotnik, A., and Yoshie, O. (2000). Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.